IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026

Go back to IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
(NASDAQ: ICCM) Delayed: 1.02 -0.06 (5.56%)
Previous Close $1.08    52 Week High $ 
Open $1.06    52 Week Low $ 
Day High $1.12    P/E N/A 
Day Low $1.01    EPS $ 
Volume 167,127